LDLR

There are 224 papers on LDLR in aging research: 12 trials and 53 observational studies in people, 117 in animals, 5 in cells, 32 reviews. The newest story, Nov 16, 2026: “Loss of nuclear support proteins harms mouse hearts and arteries”.

Gene

224 papers study it46 findings

HGNCNCBI GeneTaxon

22 new papers in 30 daysSee all 224 papers on LDLR

At a glance

A human genetic study links an LDLR-based proxy for LDL-cholesterol lowering with longer lifespan and lower coronary heart disease risk. Independent labs reproduce human LDL-cholesterol associations and mouse spatial memory impairment, although a human LDL-cholesterol finding points the other way and a mouse study reports memory protection. An author has a company affiliation, and some papers declare company ties.

46 findings in 34 papers from 2004 to 2026, 9 of them since April 2026

Independent labs found the same change in mice and people. 22 independent labs in 12 countries.

“We identify allelic series of variants associated with reduced LDL-C, including loss-of-function variants in DNAJC13 and variants in the 3-prime untranslated region of LDLR.”
Federated cross-biobank conditional analysis identifies LDL-C lowering effects of DNAJC13 haploinsufficiency and LDLR regulationbioRxiv2026doi:10.64898/2026.02.03.702791

1 of its findings points the other way.

Mice and humans: replicated by independent labs. Cells: a single group. Worms or flies: nothing yet.
  • 22 independent labs in 12 countries
  • 1 finding against
  • Funders: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior and others
  • 4 of 36 findings with company ties
  • Human trial12
  • Humans53
  • Animals117
  • Cells5

Interventions

6

Resveratrol

upin human cells1upin mice1

2 studies
  1. Resveratrol increases LDLR in SAMP8 mice.

    “Parameters related to cholesterol trafficking were also modulated, with increased LDL receptor levels, but without affecting ApoE.”

    Animalsin SAMP8 micecerebellum

    Resveratrol induces molecular changes in cholesterol homeostasis in SAMP8 mice cerebellum

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  2. Resveratrol increases LDLR in HepG2 cells.

    “RSV significantly enhanced the stability of LDLR mRNA and promoted LDLR protein expression.”

    Cellsin HepG2 cells

    Resveratrol improved atherosclerosis by increasing LDLR levels via the EGFR-ERK1/2 signaling pathway

    Lipids in health and disease

More on Resveratrol

Berberine

upin Cricetinae1upin reviews1

2 studies
  1. Berberine increases LDLR.

    “Berberine upregulates the LDL receptor (LDLR) by a mechanism distinct from that of the statins, which involves stabilising the LDLR mRNA.”

    Review

    Berberine--a novel approach to cholesterol lowering

    Expert opinion on investigational drugs

  2. Berberine increases LDLR in Cricetinae (hyperlipidemia) (2.6-fold).

    “with a 3.5-fold increase in hepatic LDLR mRNA and a 2.6-fold increase in hepatic LDLR protein”

    Animalshyperlipidemialiver

    Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

    Nature medicine

More on Berberine

Cinaciguat

upin rats1

1 study
  1. Cinaciguat increases LDLR in rats.

    “Treatment reversed age-associated loss of LDLR and LRP1 surface expression in rat hepatocytes.”

    Animalsliver

    Activating soluble guanylate cyclase restores amyloid-beta and LDL clearance in aged rats

    The Journal of biological chemistry

More on Cinaciguat

Statins

upin reviews1

1 study
  1. Statins increase LDLR.

    “increases low density lipoprotein (LDL) receptor (LDLR) expression”

    Review

    Multiphasic Venture of Cholesterol Homeostasis: A Perspective on Statin Therapy

    Journal of biochemical and molecular toxicology

More on Statins

Curcumin

upin humans1

1 study
  1. Curcumin increases LDLR in humans (polycystic ovary syndrome) (P < 0.001).

    “low-density lipoprotein receptor (LDLR) (P < 0.001) compared with the placebo.”

    Human trialpolycystic ovary syndrome500 mg/day12 weeksfemalesn = 60

    Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial

    Clinical nutrition ESPEN

More on Curcumin

Berberine + simvastatin

upin rats1

1 study
  1. Berberine + simvastatin increases LDLR in food-induced hyperlipidemic rats (1.6-fold).

    “Combination of BBR with SIMVA up-regulated the LDLR messenger RNA in rat livers to a level about 1.6-fold higher than the monotherapies did.”

    Animalsin food-induced hyperlipidemic ratsliver

    Combination of simvastatin with berberine improves the lipid-lowering efficacy

    Metabolism: clinical and experimental

More on Berberine + simvastatin

Effects

18

Spatial memory

downin mice2

2 studies
  1. LDLR impairs spatial memory in mice (LDLr-/-).

    “Spatial memory impairments were observed in LDLr-/- mice regardless of sex or age.”

    AnimalsLDLr-/-

    Sex- and age-dependent mitochondrial dysfunction and cognitive impairment in a mouse model of familial hypercholesterolemia

    Biology of sex differences

  2. LDLR impairs spatial memory in mice.

    “Spatial memory impairments were observed in LDLr −/− mice regardless of sex or age.”

    Animals

    Sex- and Age-Dependent Mitochondrial Dysfunction Links Familial Hypercholesterolemia to Cognitive Impairment

    Research SquarePreprint

Oxidative phosphorylation

downin mice1

1 study
  1. LDLR impairs oxidative phosphorylation in mice (LDLr-/-).

    “BAT respiration was impaired in both sexes at middle-aged animals, affecting distinct respiratory parameters.”

    AnimalsLDLr-/-brown adipose tissue

    Sex- and age-dependent mitochondrial dysfunction and cognitive impairment in a mouse model of familial hypercholesterolemia

    Biology of sex differences

  2. LDLR decreases oxidative phosphorylation in mice (LDLr-/-).

    “Hippocampal oxygen consumption was reduced in adult males and middle-aged female mice”

    AnimalsLDLr-/-hippocampus

    Sex- and age-dependent mitochondrial dysfunction and cognitive impairment in a mouse model of familial hypercholesterolemia

    Biology of sex differences

More on Oxidative phosphorylation

LDL-cholesterol uptake

upin human cells1

1 study
  1. LDLR increases LDL-cholesterol uptake in human cells (gain-of-function variants in class A repeat 5).

    “The screen also reveals a cluster of gain-of-function variants in LDLR class A repeat 5, at least some of which enhance LDL-C uptake through increased apolipoprotein B interaction”

    Cellsgain-of-function variants in class A repeat 5

    Screen in cells may help classify cholesterol gene variants

    Circulation

More on LDL-cholesterol uptake

Wnt/β-catenin signaling

upin mice1

1 study
  1. LDLR activates wnt/β-catenin signaling in mice (shown by knockdown).

    “activated the β-catenin signaling pathway through post-transcriptional regulation of FZD7 and LRP5”

    Animalsshown by knockdownskeletal muscle8 weeksfemalesn = 6

    LDL receptor affects the skeletal muscle and bone microstructure of female mouse through the Wnt/β-catenin signaling pathway

    Journal of molecular histology

More on Wnt/β-catenin signaling

Trabecular bone microstructure

upin mice1

1 study
  1. LDLR improves trabecular bone microstructure in mice (shown by knockdown).

    “improved trabecular parameters (including bone volume BV, bone surface BS, and trabecular thickness Tb.Th)”

    Animalsshown by knockdownbone8 weeksfemalesn = 6

    LDL receptor affects the skeletal muscle and bone microstructure of female mouse through the Wnt/β-catenin signaling pathway

    Journal of molecular histology

Grip strength

upin mice1

1 study
  1. LDLR improves grip strength in mice (shown by knockdown).

    “LDLR knockdown in E-KD mice significantly enhanced grip strength”

    Animalsshown by knockdownskeletal muscle8 weeksfemalesn = 6

    LDL receptor affects the skeletal muscle and bone microstructure of female mouse through the Wnt/β-catenin signaling pathway

    Journal of molecular histology

DHEA-S

is required forin reviews1

1 study
  1. LDLR is required for DHEA-S.

    “Broad reduction of LDLR across cortex limits cholesterol import reduces DHEA-S, linking substrate scarcity to endocrine decline.”

    Reviewadrenal cortex

    Adrenal Aging: Region-Specific Vulnerability and Proteostatic Decline - Mechanisms, Biomarkers, and Translational Opportunities

    Aging and disease

More on DHEA-S

Callus bone volume

upin mice1

1 study
  1. LDLR increases callus bone volume in mice under high-fat diet after rib resection; shown by deletion compared with wild-type mice.

    “under HFD, callus bone volume was significantly reduced exclusively in male Ldlr-/- mice when compared to WT”

    Animalsunder high-fat diet after rib resection; shown by deletion compared with wild-type micerib callusmales

    Acute hyperlipidemia has transient effects on large-scale bone regeneration in male mice

    Scientific reports

DHEA-S secretion

upin human cells1

1 study
  1. LDLR increases DHEA-S secretion in human cells (shown by targeted inactivation).

    “its targeted inactivation in human adrenal cells compromised cholesterol uptake and secretion of dehydroepiandrosterone sulfate”

    Cellsshown by targeted inactivationadrenal cells

    Aging induces region-specific dysregulation of hormone synthesis in the primate adrenal gland

    Nature aging

More on DHEA-S secretion

Cholesterol uptake

upin human cells1

1 study
  1. LDLR increases cholesterol uptake in human cells (shown by targeted inactivation).

    “its targeted inactivation in human adrenal cells compromised cholesterol uptake and secretion of dehydroepiandrosterone sulfate”

    Cellsshown by targeted inactivationadrenal cells

    Aging induces region-specific dysregulation of hormone synthesis in the primate adrenal gland

    Nature aging

All 18

Upstream

1

PCSK9

downin reviews2

2 studies
  1. PCSK9 decreases LDLR.

    “It mainly promotes the degradation of low-density lipoprotein receptor (LDL-R) by binding LDL-R, reducing low-density lipoprotein cholesterol (LDL-C) clearance.”

    Review

    PCSK9 Inhibition: From Current Advances to Evolving Future

    Cells

  2. PCSK9 decreases LDLR.

    “Once inside the cell, PCSK-9 catalyzes the proteolysis of LDLR, preventing its recycling to the cell surface, and effectively decreasing the number of LDLR”

    Review

    Keep recycling going: New approaches to reduce LDL-C

    Biochemical pharmacology

More on PCSK9

Associations

11

Familial hypercholesterolemia

upin humans4

4 studies
  1. LDLR is associated with familial hypercholesterolemia in humans (putative pathogenic variants in community screening) (11 of 13 carriers with variants in LDLR).

    “with the majority (11/13) in LDLR”

    Humansputative pathogenic variants in community screeningn = 13

    Cascade screening and genetic variant pathogenicity assessment for familial hypercholesterolemia in a township‑based elderly population

    Lipids in health and disease

  2. LDLR is associated with familial hypercholesterolemia in humans (pathogenic LDLR variant).

    “The third demonstrates genetically confirmed familial hypercholesterolemia due to a pathogenic LDLR variant despite absent classic physical stigmata.”

    Reviewpathogenic LDLR variant

    Beyond LDL-C: A Case-Based Review of Complex Dyslipidemia

    The American journal of the medical sciences

  3. LDLR is associated with familial hypercholesterolemia in humans.

    “FH is caused by pathogenic variants in the LDL receptor (LDLR) gene, or in genes encoding proteins involved in receptor-mediated LDL particle uptake”

    Review

    Familial Hypercholesterolemia

    Methodist DeBakey cardiovascular journal

  4. LDLR is associated with familial hypercholesterolemia in humans.

    “Most cases are caused by autosomal dominant mutations in LDLR, which encodes the LDL receptor”

    Review

    Familial hypercholesterolaemia

    Nature reviews. Disease primers

More on Familial hypercholesterolemia

LDL cholesterol

upin humans2downin humans1

3 studies
  1. LDLR is associated with LDL cholesterol in humans (Rare functional LDLR variants) (40–53% higher LDL-C).

    “LDLR variants with 40–53% higher LDL-C.”

    HumansRare functional LDLR variants

    Genetically mediated differences in LDL cholesterol were not consistently associated with venous thromboembolism: rare variant analyses in over 700,000 participants

    ESC Congress 2026 abstract

  2. LDLR is associated with LDL cholesterol in humans.

    “We identify allelic series of variants associated with reduced LDL-C, including loss-of-function variants in DNAJC13 and variants in the 3-prime untranslated region of LDLR.”

    Humansn = 614,375

    Federated cross-biobank conditional analysis identifies LDL-C lowering effects of DNAJC13 haploinsufficiency and LDLR regulation

    bioRxivPreprint

  3. LDLR is associated with LDL cholesterol in humans (Homozygous LDLR exon deletions or duplications) (Highest LDL-C levels among the reported genotypes).

    “individuals with homozygous LDLR exon deletions/duplications had the highest LDL-C levels.”

    HumansHomozygous LDLR exon deletions or duplications

    A nationwide genetic and phenotypic spectrum of 63 probands of homozygous familial hypercholesterolemia in Taiwan

    Journal of clinical lipidology

More on LDL cholesterol

Primary hyperlipoproteinemias

upin humans1

1 study
  1. LDLR is associated with primary hyperlipoproteinemias in humans.

    “pathogenic variants affecting LDLR, APOB, PCSK9, APOE, and lipoprotein lipase pathways”

    Review

    Decoding Primary Hyperlipoproteinemias: A Focus on the Pathogenesis and Diagnosis of Familial Hypercholesterolemia and Familial Combined Hyperlipidemia

    Diagnostics (Basel, Switzerland)

More on Primary hyperlipoproteinemias

Type 2 diabetes

upin humans1OR 2.18

1 study
  1. LDLR is linked with a higher risk of type 2 diabetes in humans (TG + TT vs GG homozygotes) (10.9% vs. 5.4%; OR = 2.18, 95% CI: 1.28-3.70, p = 0.004).

    “Notably, female T allele carriers (TG + TT) had over twice the odds of T2DM compared to GG homozygotes (10.9% vs. 5.4%; OR = 2.18; 95% CI: 1.28-3.70; p = 0.004).”

    HumansTG + TT vs GG homozygotesfemalesn = 1,442

    Pleiotropic cardiometabolic effects of the LDLR rs6511720 T allele: an evaluation of genetic risk across metabolic states

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on Type 2 diabetes

Hypercholesterolemia

downin humans1OR 0.72

1 study
  1. LDLR is linked with a lower risk of hypercholesterolemia in humans under dominant model (OR = 0.72, 95% CI: 0.52-0.98, p = 0.036).

    “Females T allele carriers were significantly associated with reduced odds of LDL-C ≥130 mg/dL under dominant (OR = 0.72; 95% CI: 0.52-0.98; p = 0.036)”

    Humansunder dominant modelfemalesn = 1,442

    Pleiotropic cardiometabolic effects of the LDLR rs6511720 T allele: an evaluation of genetic risk across metabolic states

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on Hypercholesterolemia

LDL cholesterol lowering

downin humans1

1 study
  1. LDLR is associated with LDL cholesterol lowering in humans.

    “responses to statin plus ezetimibe and add-on PCSK9 inhibitors were progressively and significantly attenuated in the defective/null and null/null subgroups”

    HumansStatins plus ezetimibe treatment in homozygous familial hypercholesterolemia; defective/null and null/null genotypesn = 175

    Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype

    Atherosclerosis

Multiterritorial plaque involvement

upin humans1

1 study
  1. LDLR is associated with multiterritorial plaque involvement in humans (Familial hypercholesterolemia; LDLR group versus non-LDLR group).

    “Multiterritorial plaque involvement was more frequent in the LDLR group than the NLDLR group (P for trend <.05).”

    HumansFamilial hypercholesterolemia; LDLR group versus non-LDLR groupn = 423

    Assessment of N/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation

    Journal of the Endocrine Society

Neutrophil-to-lymphocyte ratio

upin humans1

1 study
  1. LDLR is associated with neutrophil-to-lymphocyte ratio in humans (Familial hypercholesterolemia; LDLR mutation group versus non-LDLR group) (2.27 ± 0.86 vs 2.05 ± 0.68).

    “The LDLR group exhibited an higher NLR (2.27 ± 0.86 vs 2.05 ± 0.68, P < .05) than the NLDLR group.”

    HumansFamilial hypercholesterolemia; LDLR mutation group versus non-LDLR groupn = 423

    Assessment of N/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation

    Journal of the Endocrine Society

More on Neutrophil-to-lymphocyte ratio

Dutch Lipid Clinic Network score

upin humans1

1 study
  1. LDLR is associated with Dutch Lipid Clinic Network score in humans (LDLR rs193922571 variant).

    “moderate-impact variants rs2075291 (APOA5) and rs193922571 (LDLR) showed strong correlations with the DLCN score, suggesting increased susceptibility to FH.”

    HumansLDLR rs193922571 variant

    The Genetic Landscape of Familial Hypercholesterolemia in Telangana, Southern India: Novel Mutations and Clinical Implications

    Cureus

More on Dutch Lipid Clinic Network score

Major coronary heart disease

downin humans1−23% the mediation effect

1 study
  1. LDLR is linked with a lower risk of major coronary heart disease in humans (genetic proxy for LDL-C lowering; mediation analysis) (22.8% of the mediation effect).

    “Mediation analysis revealed that the genetic mimicry of LDLR enhancement extended lifespan by reducing the risk of major coronary heart disease, accounting for 22.8% of the mediation effect.”

    Humansgenetic proxy for LDL-C lowering; mediation analysis

    Genetic insights into the association of statin and newer nonstatin drug target genes with human longevity: a Mendelian randomization analysis

    Lipids in health and disease

More on Major coronary heart disease

All 11

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 5Jan 2026: 15Feb 2026: 11Mar 2026: 11Apr 2026: 3May 2026: 2Jun 2026: 1Jul 2026: 4Aug 2026: 6Sep 2026: 12Oct 2026: 11Nov 2026: 1697 papers in 12 months
bioRxiv

Loss of nuclear support proteins harms mouse hearts and arteries

Median survival was 14.6% lower in artery-disease-prone mice lacking the proteins in blood-vessel-lining cells than in comparison mice.Median survival was 14.6% lower in artery-disease-prone mice lacking the proteins in blood-vessel-lining cells than in comparison mice.

Preprint: mouse studyMechanisms
Nature Metabolism

Blood protein model better predicts future diabetes risk

In about 20,000 UK Biobank participants, the model scored 0.86 for ranking diabetes risk, versus 0.74 for a blood-fat ratio.In about 20,000 UK Biobank participants, the model scored 0.86 for ranking diabetes risk, versus 0.74 for a blood-fat ratio.

Cohort · 20,612 peopleType 2 diabetes
Gut Microbes

Gut bacterial product changes blood fat levels in mice

Mice given a bile acid made by the gut bacterium Ruminococcus gnavus developed blood fat disturbances.Mice given a bile acid made by the gut bacterium Ruminococcus gnavus developed blood fat disturbances.

Mouse studyMechanisms
AHA Scientific Sessions 2026 Abstract

Advanced heart-kidney-metabolic stages share 90 genetic regions

In 391,836 UK Biobank participants, a 90-region genetic core spanned stages 2–4 of the syndrome, while stage 1 differed substantially.In 391,836 UK Biobank participants, a 90-region genetic core spanned stages 2–4 of the syndrome, while stage 1 differed substantially.

Genetic association · 391,836 peopleCardiovascular-kidney-metabolic syndrome

See all 224 papers on LDLR